The Reality of Personalized Medicine
The founder of OHSU's Knight Cancer institute celebrates the progress in personalized medicine for cancer patients and cites the development of Gleevec at OHSU as a shining example.
Experts & Guests
Grover Bagby, MD
Professor at Oregon Health and Science University, School of Medicine Interim Section Head for the Center of Hematologic Malignancies, OHSU Knight Cancer InstituteNow retired, Dr. Grover Bagby was the founding director of the OHSU Knight Cancer Institute but remains an active member of the hematology/oncology section at the Portland VA Medical Center. Dr. Bagby is experienced in the clinical management of acute leukemia, myelodysplasia and bone marrow failure syndromes and has ongoing funded active research projects in each one of these areas.... more >